[1] |
WANG Xiang, SUN Shuai, WANG Xinguo, NIU Liying.
Quantitative transfer relationships of Rubia yunnanensis Diels formula granules based on standard decoctions
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 891-898.
|
[2] |
CHEN Jie, QIN Kan.
Evaluation of individualized parenteral nutrition delivery
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 812-816.
|
[3] |
FU Mengjun, YAO Huihui, ZHU Kexu, WANG Xinyuan, YAO Shangchen.
Evaluation of dissolution curves of indapamide tablets between generics and reference formulation
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 763-768.
|
[4] |
HUANG Yinyin, ZHANG Liwen, LIU Jing, CHEN Jing, ZHOU Yuanhua, XU Mingzhe, YAO Shangchen, WANG Chen, ZHANG Xianhua.
Preparation, characterization and stability of three forms of prulifloxacin
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 374-378.
|
[5] |
LUO Yaqin, ZHANG Lanhong, HUANG Wei.
Comparative study on therapeutic effects of Qihuang Yiqi Shexue Formula prepared by different extraction processes on ITP model mice
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1191-1195.
|
[6] |
LUO Yaqin, CAI Qiang, HUANG Wei.
Therapeutic effect and anti-inflammatory mechanism of Qihuang Yiqi Shexue Formula in ITP model mice
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1073-1077.
|
[7] |
WANG Luyao, DENG Zhe, XIAO Suping, ZHANG Quan, OUYANG Luodan, CHEN Meng, ZHOU Haiyan, WANG Jiyong, DU Jie.
Modern Clinical Applications and Analysis of Linggui Zhugan Decoction
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1066-1069.
|
[8] |
YANG Shubin, PEI Chenchen, SHI Wei, WANG Xin, LI Na, CAO Guangshang, ZHANG Haiming, NIE Yinglan, SUN Jian.
Network Pharmacology Study of Chinese Medicine Guizhifuling Formulae
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(4): 214-220.
|
[9] |
LIU Zhen, YU Jinyang, ZHOU Jie.
Investigation and Analysis on the Status quo of Post-marketing Risk Monitoring System of TCM Formula Granules
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(8): 473-477.
|
[10] |
CHANG Yun-feng, HAO Lei, ZHANG Xiao-jian, LI Xue-li, GAO Han, LI Jun-shan.
To compare the quality of Schisandra formula particles from different manufacturers
[J]. Chinese Journal of Pharmacovigilance, 2017, 14(5): 278-282.
|
[11] |
ZHOU Ming-xia, GAO Hui-qin, PENG Xiong-ying, LI Ya-tao, LI Jun-shan, QU Yun-ping, LI Zhen-jiang.
Rapid Identification of Different Processed Products of Rehmannia Glutinosa Formula Granules by FTIR
[J]. Chinese Journal of Pharmacovigilance, 2017, 14(2): 87-89.
|
[12] |
DOU Li-wen,HUANG Na-na,FENG Qun,LI Xiao-yu,SUN Rong.
Effect Evaluation of Guanxin Danshen Formula by Combining with Effective Components on Acute Myocardial Ischemia Rats
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(3): 129-132.
|
[13] |
LV Duan-lei, ZHAO Zhi-hui, Cheng Hu.
Gaomo Therapy on Elimination of Psoas Fatigue of Weightlifter
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(11): 649-651.
|
[14] |
DOU Li-wen, , SUN Rong,.
Protective Effects of Guanxindanshen Formula Different Components on Acute Myocardial Ischemia in Rats
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(11): 641-644.
|
[15] |
HE Yong, CHEN Xiao-mao.
Analysis of Drug Risk Management Deficiencies from Current Status of Using Ketoconazole Oral Formulations
[J]. Chinese Journal of Pharmacovigilance, 2014, 11(2): 85-87.
|